Sat, Dec 20, 2014, 9:09 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Cytokinetics, Incorporated Message Board

  • dctrig dctrig Mar 4, 2013 1:57 PM Flag

    Blum Hitting The Ball Out Of The Park Today!

    One year ago, CYTK was 4th or 5th in ALS race. Today they are #1. Trial registration is very strong with data locked in summer 2013 and reslts to be presented in Milan in 2013. Blum sounded very optimistic-in the past he has been very reluctant to say Tirasemtiv reverses ALS, but today hinted that could happen!
    Last week Cytokinetics attended an FDA meeting hosting ALS patients and advocates and The FDA was very receptive to accelerated approval of promising drugs.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • For the first time Blum did not mention that a deal was in advanced stages. This could be counterintuitive as negotiating parties, especially in a buyout, insist upon a news blackout.

      I don't remember the small biotech's name, but about six years ago one presented ho-hum at a conference and then were bought out by Roche a mere 36 hours later.

      Significantly, Blum mentioned that CFO Sharon Barbari was with him at the presentation and they adjourned to the breakout room.

4.890.00(0.00%)Dec 19 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Under Armour, Inc.
NYSEFri, Dec 19, 2014 4:04 PM EST
ImmunoGen, Inc.
NASDAQFri, Dec 19, 2014 4:00 PM EST
Hertz Global Holdings, Inc.
NYSEFri, Dec 19, 2014 4:00 PM EST